Skip to content

Observation on the Clinical Efficacy of Yu Yin Li Dan Granules for the Prevention of Common Bile Duct Stone Recurrence after Endoscopic Retrograde Cholangiopancreatography (ERCP) and Its Impact on the Biliary Tract Microenvironment.

Observation on the clinical efficacy of Yuyin Li Dan granules in preventing recurrence of common bile duct stones after ERCP and its impact on the biliary microenvironment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002505
Enrollment
Unknown
Registered
2025-12-24
Start date
2024-09-18
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CommonBileDuctStones

Interventions

Treatment group:Combined general treatment after ERCP stone extraction with Yuyin Lidan Granules
Control group:Post-ERCP stone extraction with general treatment combined with ursodeoxycholic acid capsules

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the Western medical diagnostic criteria for common bile duct stones; (2) No restrictions on gender, age between 18 to 80 years old; (3) Meet the diagnostic criteria for the liver and gallbladder damp-heat syndrome of common bile duct stones; (4) Successfully stone-extracted via ERCP at this hospital, with no residual stones confirmed by imaging examinations; (5) Agree to participate in this study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Pregnant or lactating women; (2) Biliary tract malformations or biliary tract malignant tumors; (3) Patients with severe underlying diseases such as heart, brain vascular, liver, kidney, and hematopoietic system diseases, as well as patients with mental illness; (4) Patients with serious complications after surgery; (5) Patients who have previously taken Yuyin Li Dan Granules and experienced adverse reactions.

Design outcomes

Primary

MeasureTime frame
Recurrence rate of common bile duct stones;

Secondary

MeasureTime frame
Bile Biochemistry;Analysis of Biliary Tract Microbiota Diversity and Structural Components;Serological indicators;Traditional Chinese Medicine Syndrome Score;

Countries

China

Contacts

Public Contacthecong

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

546010672@qq.com18361312386

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026